Amylyx Pharmaceuticals

AMLXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.064 B

$32.39 -0.06%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$144.7M

Loss-making

Shares outstanding

111,423,048

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#62Indivior PharmaceuticalsINDV$4.19B
#63AbCellera BiologicsABCL$4.10B
#64Amylyx PharmaceuticalsAMLX$4.06B
#65Telix PharmaceuticalsTLX$3.83B
#66Xenon PharmaceuticalsXENE$3.78B

What if Amylyx Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$241,307.74

Per share 7,450× higher

Bitcoin $1.72T

$13,708.17

Per share 423× higher

Nvidia $5.48T

$43,678.73

Per share 1,349× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Amylyx Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.